BeOne Medicines AG Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	31,116	33,678	19,712	18,862	22,944	27,818
Market Cap Growth	9.88%	70.85%	4.51%	-17.79%	-17.52%	17.53%
Enterprise Value	27,460	31,130	18,165	16,606	19,006	21,895
Last Close Price	279.99	303.81	184.71	180.36	219.94	270.93
PE Ratio	61.95	123.00	-	-	-	-
Forward PE	39.39	66.95	-	-	-	-
PS Ratio	5.45	6.30	5.17	7.67	16.20	23.65
PB Ratio	6.49	7.72	5.92	5.33	5.23	4.54
P/TBV Ratio	6.83	8.02	5.93	5.41	5.22	4.13
P/FCF Ratio	26.01	35.76	-	-	-	-
P/OCF Ratio	23.02	29.87	-	-	-	-
EV/Sales Ratio	4.81	5.83	4.77	6.75	13.42	18.61
EV/EBITDA Ratio	33.43	52.87	-	-	-	-
EV/EBIT Ratio	40.17	69.62	-	-	-	-
EV/FCF Ratio	22.96	33.06	-	-	-	-
Debt / Equity Ratio	0.41	0.44	0.32	0.26	0.13	0.11
Debt / EBITDA Ratio	2.46	3.40	-	-	-	-
Debt / FCF Ratio	1.84	2.12	-	-	-	-
Net Debt / Equity Ratio	-0.57	-0.58	-0.46	-0.64	-0.90	-0.97
Net Debt / EBITDA Ratio	-3.28	-4.33	3.90	2.01	2.29	4.25
Net Debt / FCF Ratio	-2.46	-2.70	2.44	1.31	2.16	3.79
Asset Turnover	0.68	0.76	0.65	0.40	0.19	0.17
Inventory Turnover	1.04	1.21	1.30	1.09	1.09	0.99
Quick Ratio	3.16	2.96	1.49	1.96	3.21	4.44
Current Ratio	3.64	3.41	1.80	2.32	3.55	4.76
Return on Equity (ROE)	11.25%	7.46%	-18.77%	-22.26%	-38.11%	-29.15%
Return on Assets (ROA)	6.42%	4.36%	-11.72%	-21.17%	-24.52%	-20.63%
Return on Invested Capital (ROIC)	24.10%	12.00%	-25.75%	-60.23%	-102.18%	-102.75%
Return on Capital Employed (ROCE)	10.47%	8.88%	-14.76%	-27.12%	-30.21%	-25.11%
Earnings Yield	1.72%	0.81%	-	-	-	-
FCF Yield	3.84%	2.80%	-	-	-	-
Buyback Yield / Dilution	-10.10%	-7.75%	-0.86%	-1.22%	-11.15%	-11.16%
Total Shareholder Return	-10.10%	-7.75%	-0.86%	-1.22%	-11.15%	-11.16%

SEC Filings: 10-K · 10-Q